UA
50
-4
ORLY
58
-3
WBA
31
-4
SLB
60
3
COST
69
2
NWS
86
3
EQIX
45
-2
WHR
53
-6
PX
59
-3
PFE
40
8
DGX
29
-4
AVY
71
-4
AMT
62
-3
RF
45
-6
PNW
49
3
AZO
59
-4
EXR
53
-2
XYL
41
-4
SPG
56
-7
PAYX
54
-2
UA
50
-4
ORLY
58
-3
WBA
31
-4
SLB
60
3
COST
69
2
NWS
86
3
EQIX
45
-2
WHR
53
-6
PX
59
-3
PFE
40
8
DGX
29
-4
AVY
71
-4
AMT
62
-3
RF
45
-6
PNW
49
3
AZO
59
-4
EXR
53
-2
XYL
41
-4
SPG
56
-7
PAYX
54
-2
Financhill
Back

Rhythm Pharmaceuticals Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
91

RYTM
Rhythm Pharmaceuticals

Last Price:
42.80
Seasonality Move:
66.44%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
91
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $42.79. The Score for RYTM is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $42.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 58.95 Buy
Chaikin Money Flow: 68970 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.15 - 42.03) Buy
Bollinger Bands (100): (38.05 - 45.19) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.19 Buy
20-day SMA: 40.05 Buy
50-day SMA: 39.6 Buy
200-day SMA: 37.19 Buy
8-day EMA: 41.87 Buy
20-day EMA: 40.82 Buy
50-day EMA: 40.3 Buy
200-day EMA: 36.93 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.36 per share, and an increase next year of $2.03 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):